OverT Bio forms Clinical Advisory Board to advance OVT-101, a scalable CAR-T therapy targeting CLDN6 for ovarian and other solid tumors.

Phoenix-based developer Creation completed construction on Park Algodon, a $250 million industrial and mixed-use development ...

Locally based Creation has completed construction for Park Algodon, an industrial and mixed-use development at the northwest corner of Loop 101 - Arizona, Development, Mixed-use, News ...

A public-private partnership between the University of Mississippi (Ole Miss) and Charleston-based Greystar has broken ground ...

Monopar Therapeutics Inc. ('Monopar,” the 'Company,” 'we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...

Creation, a Phoenix-based developer, has completed construction for Park Algodon, an industrial and mixed-use development at the northwest corner of Loop 101 and Indian School Road in Phoenix.

The move brings four key organizations together under one roof, aligning efforts in economic growth, business support and downtown vitality.

Exciting times for Columbia's BullStreet District! With the opening of Three Notch’d Brewery and Amarok’s HQ plans bringing ...

Growth continues in Lexington as plans move forward for a large dealership and future commercial development on West Main ...

Completed a US$57.2 million equity financing; commenced trading on the Nasdaq Global Market under the ticker 'MSLE” on Feb. 6 ...

Monopar Therapeutics Inc. ("Monopar," the "Company," "we") (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments ...